drugset / Trial / NCT00414323

Evaluation of the Effects of Duloxetine on Norepinephrine

NCT00414323

Phase 1 Completed 35 enrolled Eli Lilly and Company
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to evaluate how taking duloxetine 60mg every day affects the transfer of two normal body chemicals, 3,4-dihydroxyphenylglycol (DHPG) and norepinephrine (NE), across cells in blood and cerebrospinal fluid.

Timeline

Start
2006-11
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg
Subject Escitalopram Small molecule